首页> 外国专利> COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF BCL-2 AND BCL-XL ANTAGONISTS

COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF BCL-2 AND BCL-XL ANTAGONISTS

机译:Bcl-2和Bcl-XL拮抗剂的全身递送的组合物和方法

摘要

This disclosure provides compositions and methods for albumin nanoformulation of Bcl-2 and Bcl-xL inhibitor APG-1252 to suppress and/or inhibit growth of cancer cells (e.g., tumor cells). In particular, the present invention is directed to compositions comprising nanoparticles associated with (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) APG- 1252, methods for synthesizing such nanoparticles, as well as systems and methods utilizing such nanoparticles (e.g., in diagnostic and/or therapeutic settings). Such nanoparticle formulations of APG-1252 are capable of increasing solubility, protecting against its degradation, reducing platelet toxicity, and expanding (improving) different indications to improve anticancer efficacy in various cancers and cancer metastasis in lymph nodes.
机译:本公开提供了用于Bcl-2和Bcl-XL抑制剂APG-1252的白蛋白纳米型纳米蛋白酶的组合物和方法,以抑制和/或抑制癌细胞的生长(例如,肿瘤细胞)。特别地,本发明涉及包含与(例如,络合,缀合,包封,吸收的,吸附,混合)APG-1252相关的纳米颗粒的组合物,用于合成这种纳米颗粒的方法,以及利用这种纳米颗粒的系统和方法(例如,诊断和/或治疗设置)。 APG-1252的这种纳米颗粒制剂能够增加溶解度,免受其降解,降低血小板毒性,并扩张(改善)不同的适应症,以改善淋巴结中各种癌症和癌症转移中的抗癌功效。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号